U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 133

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr20:31023072
GRCh38:
Chr20:32435269
ASXL1P792fs, P853fsBohring-Opitz syndromeLikely pathogenic
(Mar 23, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr20:31024769-31024775
GRCh38:
Chr20:32436966-32436972
ASXL1K1358fs, K1419fsBohring-Opitz syndromePathogenic
(Sep 10, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr20:31021366-31021369
GRCh38:
Chr20:32433563-32433566
ASXL1D396fs, D457fsBohring-Opitz syndromePathogenic
(Apr 20, 2023)
criteria provided, single submitter
4.
GRCh37:
Chr20:31020776
GRCh38:
Chr20:32432973
ASXL1Y297C, Y358CBohring-Opitz syndromeUncertain significance
(Aug 22, 2019)
criteria provided, single submitter
5.
GRCh37:
Chr20:31024021
GRCh38:
Chr20:32436218
ASXL1S1108F, S1169FBohring-Opitz syndromeUncertain significance
(Dec 13, 2021)
criteria provided, single submitter
6.
GRCh37:
Chr20:31024665
GRCh38:
Chr20:32436862
ASXL1N1323D, N1384DBohring-Opitz syndromeUncertain significance
(May 13, 2020)
criteria provided, single submitter
7.
GRCh37:
Chr20:31024719
GRCh38:
Chr20:32436916
ASXL1M1341V, M1402VBohring-Opitz syndromeUncertain significance
(Nov 2, 2020)
criteria provided, single submitter
8.
GRCh37:
Chr20:31024362
GRCh38:
Chr20:32436559
ASXL1G1222S, G1283SBohring-Opitz syndromeUncertain significance
(Mar 3, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr20:31022686
GRCh38:
Chr20:32434883
ASXL1L663P, L724PBohring-Opitz syndromeUncertain significance
(Nov 13, 2020)
criteria provided, single submitter
10.
GRCh37:
Chr20:31023393
GRCh38:
Chr20:32435590
ASXL1W960G, W899GBohring-Opitz syndrome, Inborn genetic diseasesUncertain significance
(Oct 4, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr20:31024561
GRCh38:
Chr20:32436758
ASXL1V1288A, V1349Anot provided, Bohring-Opitz syndromeUncertain significance
(Jul 25, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr20:31024651
GRCh38:
Chr20:32436848
ASXL1K1318T, K1379TBohring-Opitz syndromeUncertain significance
(Sep 2, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr20:31022824
GRCh38:
Chr20:32435021
ASXL1S709L, S770LBohring-Opitz syndromeUncertain significance
(Feb 2, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr20:31024454-31024469
GRCh38:
Chr20:32436651-32436666
ASXL1Q1254fs, Q1315fsBohring-Opitz syndromePathogenic
(Nov 10, 2020)
criteria provided, single submitter
15.
GRCh37:
Chr20:31021436-31021437
GRCh38:
Chr20:32433633-32433634
ASXL1P418fs, P479fsBohring-Opitz syndromePathogenicno assertion criteria provided
16.
GRCh37:
Chr20:31024080
GRCh38:
Chr20:32436277
ASXL1A1128T, A1189TBohring-Opitz syndromeUncertain significance
(Apr 19, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr20:31021699
GRCh38:
Chr20:32433896
ASXL1E505D, E566DBohring-Opitz syndromeLikely benign
(Mar 3, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr20:31024192-31024193
GRCh38:
Chr20:32436389-32436390
ASXL1L1165fs, L1226fsBohring-Opitz syndromeLikely pathogenic
(Sep 1, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr20:31022544
GRCh38:
Chr20:32434741
ASXL1P616S, P677SBohring-Opitz syndromeUncertain significance
(Aug 12, 2021)
criteria provided, single submitter
20.
GRCh37:
Chr20:31025138-31025140
GRCh38:
Chr20:32437335-32437337
ASXL1Bohring-Opitz syndromeUncertain significance
(Aug 12, 2021)
criteria provided, single submitter
21.
GRCh37:
Chr20:31022235
GRCh38:
Chr20:32434432
ASXL1I513V, I574VBohring-Opitz syndromePathogenic
(Aug 16, 2022)
no assertion criteria provided
22.
GRCh37:
Chr20:31021694
GRCh38:
Chr20:32433891
ASXL1E504Q, E565QBohring-Opitz syndromeUncertain significance
(Jun 24, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr20:31021611
GRCh38:
Chr20:32433808
ASXL1E476G, E537GBohring-Opitz syndromeUncertain significance
(Feb 2, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr20:31022838
GRCh38:
Chr20:32435035
ASXL1Bohring-Opitz syndromeLikely pathogenic
(Jun 4, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr20:31024430
GRCh38:
Chr20:32436627
ASXL1F1244L, F1305LBohring-Opitz syndromeUncertain significance
(Apr 16, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr20:31023817
GRCh38:
Chr20:32436014
ASXL1V1040E, V1101EBohring-Opitz syndrome, Myelodysplastic syndromeUncertain significance
(Jul 13, 2021)
criteria provided, single submitter
27.
GRCh37:
Chr20:31024136
GRCh38:
Chr20:32436333
ASXL1Bohring-Opitz syndrome, Myelodysplastic syndrome, not provided
Likely benign
(Sep 19, 2021)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr20:31022443
GRCh38:
Chr20:32434640
ASXL1G582A, G643Anot provided, Bohring-Opitz syndromeConflicting interpretations of pathogenicity
(Feb 9, 2022)
criteria provided, conflicting interpretations
29.
GRCh37:
Chr20:31022265-31022266
GRCh38:
Chr20:32434462-32434463
ASXL1V524fs, V585fsBohring-Opitz syndromeLikely pathogenic
(Feb 5, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr20:31020718
GRCh38:
Chr20:32432915
ASXL1Q278*, Q339*Bohring-Opitz syndromeLikely pathogenic
(Nov 24, 2021)
criteria provided, single submitter
31.
GRCh37:
Chr20:31024858
GRCh38:
Chr20:32437055
ASXL1Q1387R, Q1448RBohring-Opitz syndrome, not providedBenign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr20:31025163
GRCh38:
Chr20:32437360
ASXL1not provided, Bohring-Opitz syndromeBenign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr20:30954295
GRCh38:
Chr20:32366492
ASXL1Bohring-Opitz syndrome, not providedBenign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr20:31023750
GRCh38:
Chr20:32435947
ASXL1S1018P, S1079PInborn genetic diseases, not provided, Bohring-Opitz syndrome
Benign/Likely benign
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr20:31021521
GRCh38:
Chr20:32433718
ASXL1I446N, I507Nnot provided, Bohring-Opitz syndromeBenign/Likely benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr20:31025231
GRCh38:
Chr20:32437428
ASXL1not provided, Bohring-Opitz syndromeBenign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr20:31024480
GRCh38:
Chr20:32436677
ASXL1P1322R, P1261Rnot provided, Inborn genetic diseases, Bohring-Opitz syndrome
Benign/Likely benign
(Jul 28, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr20:31023108
GRCh38:
Chr20:32435305
ASXL1E804K, E865Knot provided, Inborn genetic diseases, Bohring-Opitz syndrome
Benign/Likely benign
(Oct 16, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr20:31019024
GRCh38:
Chr20:32431221
ASXL1Bohring-Opitz syndrome, not providedBenign
(Jul 14, 2021)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr20:31023272-31023273
GRCh38:
Chr20:32435469-32435470
ASXL1V861fs, V922fsBohring-Opitz syndromePathogenic
(Feb 14, 2020)
no assertion criteria provided
41.
GRCh37:
Chr20:31022737
GRCh38:
Chr20:32434934
ASXL1D680V, D741VBohring-Opitz syndrome, not providedBenign
(Oct 16, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr20:31021721
GRCh38:
Chr20:32433918
ASXL1Bohring-Opitz syndromePathogenic
(Feb 17, 2021)
no assertion criteria provided
43.
GRCh37:
Chr20:30946654
GRCh38:
Chr20:32358851
ASXL1not provided, Bohring-Opitz syndrome, Myelodysplastic syndrome,
Bohring-Opitz syndrome
Benign/Likely benign
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr20:31023942
GRCh38:
Chr20:32436139
ASXL1S1082R, S1143Rnot provided, Bohring-Opitz syndromeBenign/Likely benign
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr20:31021568
GRCh38:
Chr20:32433765
ASXL1K462*, K523*Bohring-Opitz syndromeLikely pathogenic
(Jul 3, 2020)
criteria provided, single submitter
46.
GRCh37:
Chr20:30954198
GRCh38:
Chr20:32366395
ASXL1Y14fs, Y24fsBohring-Opitz syndromeLikely pathogenic
(Dec 6, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr20:31023952
GRCh38:
Chr20:32436149
ASXL1S1085*, S1146*Bohring-Opitz syndromePathogenic
(May 11, 2018)
criteria provided, single submitter
48.
GRCh37:
Chr20:31021590
GRCh38:
Chr20:32433787
ASXL1A469V, A530VBohring-Opitz syndromeUncertain significance
(Apr 3, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr20:31021388
GRCh38:
Chr20:32433585
ASXL1S463G, S402GBohring-Opitz syndromeUncertain significance
(Jul 24, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr20:31024461
GRCh38:
Chr20:32436658
ASXL1R1255G, R1316GBohring-Opitz syndromeUncertain significance
(Nov 20, 2019)
criteria provided, single submitter
51.
GRCh37:
Chr20:31021226
GRCh38:
Chr20:32433423
ASXL1K348E, K409EBohring-Opitz syndromeUncertain significance
(Mar 19, 2020)
criteria provided, single submitter
52.
GRCh37:
Chr20:31017781
GRCh38:
Chr20:32429978
ASXL1A215TBohring-Opitz syndromeLikely pathogenic
(May 31, 2019)
no assertion criteria provided
53.
GRCh37:
Chr20:31017796
GRCh38:
Chr20:32429993
ASXL1Q220*Bohring-Opitz syndromeLikely pathogenic
(May 31, 2019)
no assertion criteria provided
54.
GRCh37:
Chr20:31023940
GRCh38:
Chr20:32436137
ASXL1Q1081R, Q1142RBohring-Opitz syndromeUncertain significance
(Jan 1, 2019)
criteria provided, single submitter
55.
GRCh37:
Chr20:31024563
GRCh38:
Chr20:32436760
ASXL1Q1289*, Q1350*Bohring-Opitz syndromePathogenic
(Dec 20, 2017)
criteria provided, single submitter
56.
GRCh37:
Chr20:31022234
GRCh38:
Chr20:32434431
ASXL1Bohring-Opitz syndromePathogenic
(Jun 24, 2019)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr20:31022403-31022425
GRCh38:
Chr20:32434600-32434622
ASXL1E635fs, E574fsnot provided, Bohring-Opitz syndromePathogenic/Likely pathogenic
(Aug 1, 2021)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr20:31022547-31022548
GRCh38:
Chr20:32434744-32434745
ASXL1G619fs, G680fsBohring-Opitz syndromePathogenic
(Jun 11, 2019)
criteria provided, single submitter
59.
GRCh37:
Chr20:31023975
GRCh38:
Chr20:32436172
ASXL1G1154S, G1093SBohring-Opitz syndromeUncertain significance
(May 28, 2019)
criteria provided, single submitter
60.
GRCh37:
Chr20:31021426-31021427
GRCh38:
Chr20:32433623-32433624
ASXL1E477fs, E416fsBohring-Opitz syndromePathogenic
(May 28, 2019)
criteria provided, single submitter
61.
GRCh37:
Chr20:31021466
GRCh38:
Chr20:32433663
ASXL1R428G, R489Gnot provided, Bohring-Opitz syndromeBenign/Likely benign
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr20:31024985
GRCh38:
Chr20:32437182
ASXL1L1490F, L1429FInborn genetic diseases, not provided, Bohring-Opitz syndrome
Benign/Likely benign
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr20:31024448
GRCh38:
Chr20:32436645
ASXL1not provided, Bohring-Opitz syndromeBenign/Likely benign
(Jul 12, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr20:31022413
GRCh38:
Chr20:32434610
ASXL1H572R, H633Rnot provided, Bohring-Opitz syndromeBenign/Likely benign
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr20:31022438
GRCh38:
Chr20:32434635
ASXL1Bohring-Opitz syndrome, not providedBenign/Likely benign
(Oct 29, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr20:31024055
GRCh38:
Chr20:32436252
ASXL1Bohring-Opitz syndrome, not providedBenign/Likely benign
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr20:31023788
GRCh38:
Chr20:32435985
ASXL1Bohring-Opitz syndrome, not providedBenign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr20:31021332
GRCh38:
Chr20:32433529
ASXL1S383L, S444LInborn genetic diseases, not provided, Bohring-Opitz syndrome
Benign/Likely benign
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr20:31021634
GRCh38:
Chr20:32433831
ASXL1R484C, R545CBohring-Opitz syndrome, not providedBenign/Likely benign
(Aug 31, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr20:31023899
GRCh38:
Chr20:32436096
ASXL1Bohring-Opitz syndrome, not providedBenign
(Jul 26, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr20:31024254
GRCh38:
Chr20:32436451
ASXL1R1186C, R1247Cnot provided, Bohring-Opitz syndromeBenign/Likely benign
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr20:31022574
GRCh38:
Chr20:32434771
ASXL1C626R, C687RBohring-Opitz syndrome, Bohring-Opitz syndrome, Myelodysplastic syndrome,
not provided
Benign/Likely benign
(Oct 1, 2022)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr20:31023409-31023411
GRCh38:
Chr20:32435606-32435608
ASXL1G906del, G967delBohring-Opitz syndrome, not providedConflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
74.
GRCh37:
Chr20:31017209
GRCh38:
Chr20:32429406
ASXL1Bohring-Opitz syndrome, not providedBenign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr20:31022929-31022930
GRCh38:
Chr20:32435126-32435127
ASXL1V807fs, V746fsBohring-Opitz syndromePathogeniccriteria provided, single submitter
76.
GRCh37:
Chr7:23164330
GRCh38:
Chr7:23124711
KLHL7F35fs, F83fsBohring-Opitz syndromePathogenic
(Apr 12, 2019)
criteria provided, single submitter
77.
GRCh37:
Chr20:31024284
GRCh38:
Chr20:32436481
ASXL1A1196fs, A1257fsBohring-Opitz syndromeLikely pathogenic
(Jan 1, 2015)
criteria provided, single submitter
78.
GRCh37:
Chr20:31024150
GRCh38:
Chr20:32436347
ASXL1L1213fs, L1152fsBohring-Opitz syndromeLikely pathogenic
(Nov 6, 2018)
criteria provided, single submitter
79.
GRCh37:
Chr20:31024575
GRCh38:
Chr20:32436772
ASXL1E1354*, E1293*Bohring-Opitz syndromePathogenic
(Jun 13, 2018)
criteria provided, single submitter
80.
GRCh37:
Chr20:31022592
GRCh38:
Chr20:32434789
ASXL1R693*, R632*not provided, Bohring-Opitz syndrome, Myelodysplastic syndrome
Pathogenic/Likely pathogenic
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr20:31021284-31021285
GRCh38:
Chr20:32433481-32433482
ASXL1Q428fs, Q367fsBohring-Opitz syndromePathogenic
(May 14, 2018)
criteria provided, single submitter
82.
GRCh37:
Chr20:31024795-31024797
GRCh38:
Chr20:32436992-32436994
ASXL1S1429del, S1368delBohring-Opitz syndrome, Myelodysplastic syndrome, not provided
Uncertain significance
(Sep 29, 2021)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr20:31024215
GRCh38:
Chr20:32436412
ASXL1Q1234*, Q1173*Bohring-Opitz syndromePathogenic
(Sep 1, 2017)
criteria provided, single submitter
84.
GRCh37:
Chr20:31024624-31024626
GRCh38:
Chr20:32436821-32436823
ASXL1K1371del, K1310delMyelodysplastic syndrome, not provided, Bohring-Opitz syndrome
Uncertain significance
(May 17, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr20:31024636-31024637
GRCh38:
Chr20:32436833-32436834
ASXL1P1377fs, P1316fsnot provided, Inborn genetic diseases, Myelodysplastic syndrome,
Bohring-Opitz syndrome
Pathogenic/Likely pathogenic
(May 3, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr20:30956891
GRCh38:
Chr20:32369088
ASXL1K73*, K63*Bohring-Opitz syndromePathogenic
(Dec 11, 2017)
criteria provided, single submitter
87.
GRCh37:
Chr20:31024265-31024269
GRCh38:
Chr20:32436462-32436466
ASXL1Bohring-Opitz syndromePathogenic
(Jun 20, 2017)
no assertion criteria provided
88.
GRCh37:
Chr20:31023717
GRCh38:
Chr20:32435914
ASXL1R1068*, R1007*not provided, Bohring-Opitz syndromePathogenic
(Nov 8, 2022)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr20:31022441-31022442
GRCh38:
Chr20:32434638-32434639
ASXL1G585fs, G646fsBohring-Opitz syndrome, Abnormality of brain morphology, not provided
Pathogenic/Likely pathogenic
(Oct 3, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr20:31026697-31026698
GRCh38:
Chr20:32438894-32438895
ASXL1Bohring-Opitz syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
91.
GRCh37:
Chr20:31024613
GRCh38:
Chr20:32436810
ASXL1not provided, Bohring-Opitz syndromeBenign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr20:31024274
GRCh38:
Chr20:32436471
ASXL1not specified, not provided, Bohring-Opitz syndrome
Benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr20:31024028
GRCh38:
Chr20:32436225
ASXL1not provided, Bohring-Opitz syndromeBenign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr20:31023866
GRCh38:
Chr20:32436063
ASXL1not provided, Bohring-Opitz syndromeConflicting interpretations of pathogenicity
(Sep 12, 2022)
criteria provided, conflicting interpretations
95.
GRCh37:
Chr20:31023727
GRCh38:
Chr20:32435924
ASXL1A1071V, A1010Vnot provided, Bohring-Opitz syndromeConflicting interpretations of pathogenicity
(Jun 13, 2022)
criteria provided, conflicting interpretations
96.
GRCh37:
Chr20:31023544
GRCh38:
Chr20:32435741
ASXL1T1010M, T949Mnot provided, Bohring-Opitz syndromeBenign/Likely benign
(Oct 16, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr20:31023500
GRCh38:
Chr20:32435697
ASXL1not provided, Bohring-Opitz syndromeBenign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr20:31023317
GRCh38:
Chr20:32435514
ASXL1not provided, Bohring-Opitz syndromeBenign/Likely benign
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr20:31023059
GRCh38:
Chr20:32435256
ASXL1not provided, Bohring-Opitz syndromeLikely benign
(Jun 27, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr20:31023041
GRCh38:
Chr20:32435238
ASXL1not provided, Bohring-Opitz syndromeBenign/Likely benign
(Sep 28, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination